Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Dhodapkar

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Clinical Immunology|August 15, 2000
Active immunization of humans with dendritic cellsM V Dhodapkar, N Bhardwaj
Leukemia & Lymphoma|June 1, 1999
Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironmentM V Dhodapkar, R D Sanderson
Hematology/Oncology Clinics of North America|February 1, 1997
Biology and therapy of immunoglobulin deposition diseasesM V Dhodapkar, G Merlini, A Solomon
Current Treatment Options in Oncology|June 12, 2002
Waldenström's macroglobulinemiaK R Desikan, M V Dhodapkar, B Barlogie
Cell Death and Differentiation|October 20, 2007
Interactions of tumor cells with dendritic cells: balancing immunity and toleranceM V Dhodapkar, K M Dhodapkar, A K Palucka
Mayo Clinic Proceedings|November 1, 1994
T-cell large granular lymphocytic leukemia and pure red cell aplasia in a patient with type I autoimmune polyendocrinopathy: response to immunosuppressive therapyM V Dhodapkar, J A Lust, R L Phyliky
Cancer|January 1, 1995
Estrogen replacement therapy withdrawal and regression of metastatic breast cancerM V Dhodapkar, J N Ingle, D L Ahmann
The Journal of Clinical Investigation|March 23, 2000
Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopesM V Dhodapkar, J Krasovsky, R M Steinman, et al.
Current Opinion in Hematology|July 10, 1999
Recent advances in the treatment of multiple myelomaK R Desikan, M V Dhodapkar, N C Munshi, et al.
Investigational New Drugs|January 1, 1994
Pyrazine diazohydroxide (NSC-361456). Phase I clinical and pharmacokinetic studiesM V Dhodapkar, R L Richardson, J M Reid, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Clinical Immunology|August 15, 2000
Active immunization of humans with dendritic cellsM V Dhodapkar, N Bhardwaj
Leukemia & Lymphoma|June 1, 1999
Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironmentM V Dhodapkar, R D Sanderson
Hematology/Oncology Clinics of North America|February 1, 1997
Biology and therapy of immunoglobulin deposition diseasesM V Dhodapkar, G Merlini, A Solomon
Current Treatment Options in Oncology|June 12, 2002
Waldenström's macroglobulinemiaK R Desikan, M V Dhodapkar, B Barlogie
Cell Death and Differentiation|October 20, 2007
Interactions of tumor cells with dendritic cells: balancing immunity and toleranceM V Dhodapkar, K M Dhodapkar, A K Palucka
Mayo Clinic Proceedings|November 1, 1994
T-cell large granular lymphocytic leukemia and pure red cell aplasia in a patient with type I autoimmune polyendocrinopathy: response to immunosuppressive therapyM V Dhodapkar, J A Lust, R L Phyliky
Cancer|January 1, 1995
Estrogen replacement therapy withdrawal and regression of metastatic breast cancerM V Dhodapkar, J N Ingle, D L Ahmann
The Journal of Clinical Investigation|March 23, 2000
Mature dendritic cells boost functionally superior CD8(+) T-cell in humans without foreign helper epitopesM V Dhodapkar, J Krasovsky, R M Steinman, et al.
Current Opinion in Hematology|July 10, 1999
Recent advances in the treatment of multiple myelomaK R Desikan, M V Dhodapkar, N C Munshi, et al.
Investigational New Drugs|January 1, 1994
Pyrazine diazohydroxide (NSC-361456). Phase I clinical and pharmacokinetic studiesM V Dhodapkar, R L Richardson, J M Reid, et al.
Pageof 3